Roche Buys GenMark Diagnostics For $1.8Bn

 
• By Reed Miller

GenMark’s syndromic panel testing portfolio complements Roche’s molecular diagnostics business.

Test tube of bacteria; 3D low poly render
• Source: shutterstock.com

More from Deals

More from Business